207 related articles for article (PubMed ID: 25470196)
21. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.
Price JC; Terrault NA
Liver Int; 2015 Jan; 35(1):7-8. PubMed ID: 25183500
[No Abstract] [Full Text] [Related]
22. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
Shiraha H; Iwasaki Y; Shiratori Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
[No Abstract] [Full Text] [Related]
23. [When and how to treat hepatitis B and C?].
Pache I; Hess J; Gonvers JJ; Moradpour D
Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in HIV positive patients.
Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C: new CDC screening recommendations.
Campos-Outcalt D
J Fam Pract; 2012 Dec; 61(12):744-6. PubMed ID: 23313992
[TBL] [Abstract][Full Text] [Related]
26. New concepts of sofosbuvir-based treatment regimens in patients with hepatitis C.
Mariño Z; van Bömmel F; Forns X; Berg T
Gut; 2014 Feb; 63(2):207-15. PubMed ID: 24253934
[No Abstract] [Full Text] [Related]
27. HIV-hepatitis C co-infection.
Hayward P
Lancet Infect Dis; 2015 Apr; 15(4):382. PubMed ID: 25809897
[No Abstract] [Full Text] [Related]
28. Trials wrap on interferon-free hepatitis C regimen.
Dalzell MD
Manag Care; 2013 Apr; 22(4):41-2. PubMed ID: 23678562
[No Abstract] [Full Text] [Related]
29. Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus.
Valla DC; Degos F
J Hepatol; 2001 Apr; 34(4):606-9. PubMed ID: 11394663
[No Abstract] [Full Text] [Related]
30. New Indications for Harvoni.
Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
[No Abstract] [Full Text] [Related]
31. [Incidence of hepatocellular carcinoma in patients treated with interferon].
Yokosuka O; Omata M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
[No Abstract] [Full Text] [Related]
32. [Screening for hepatocellular carcinoma: between cynicism or perfectionism?].
Hadengue A
Gastroenterol Clin Biol; 2003 May; 27(5):525-7. PubMed ID: 12843916
[No Abstract] [Full Text] [Related]
33. Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.
Wangensteen KJ; Chang KM
Hepatology; 2021 Jan; 73 Suppl 1(Suppl 1):27-37. PubMed ID: 32737895
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma.
Naugler WE; Schwartz JM
Dis Mon; 2008 Jul; 54(7):432-44. PubMed ID: 18570913
[No Abstract] [Full Text] [Related]
35. Interferon: benefit beyond hepatitis therapy?
Mallat DB; El-Serag HB
Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
[No Abstract] [Full Text] [Related]
36. [High risk group for development of hepatocellular carcinoma].
Koike Y; Shiratori Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
[No Abstract] [Full Text] [Related]
37. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
[No Abstract] [Full Text] [Related]
38. Dare to refuse the exorbitant price of Sovaldi!
Prescrire Int; 2014 Nov; 23(154):278. PubMed ID: 25954802
[No Abstract] [Full Text] [Related]
39. US health insurers say Gilead hepatitis C drug too costly.
Clin Infect Dis; 2014 Jul; 59(2):i-ii. PubMed ID: 25105185
[No Abstract] [Full Text] [Related]
40. Prevention of hepatocellular carcinoma.
Wands JR
N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
